Program for Recognition and Intervention in Individuals in at Risk Mental States (PRISMA), Department of Psychiatry, Universidade Federal de São Paulo, São Paulo, Brazil.
Expert Rev Neurother. 2013 Jul;13(7):795-806; quiz 807. doi: 10.1586/14737175.2013.811132.
Bipolar disorder (BD) usually follows a neurobiological progression pathway, but a relatively long interval between the first symptoms of the disorder and the correct diagnosis and treatment takes place in most patients. Strategies used to recognize BD at an early stage and even prior to the first manic episode could help identify the risk and modifying factors that influence the onset and course of disease, and improve outcomes. Drawing on current research results, this article presents considerations on risk factors for the development of BD, including genetic/familial risk, endophenotypes and clinical characteristics. Taken together, this article provides a framework and tools for research on the BD prodrome, as well as for the early recognition and timely treatment of patients prior to and immediately after the emergence of BD.
双相障碍(BD)通常遵循神经生物学进展途径,但大多数患者在出现疾病的第一个症状与得到正确诊断和治疗之间存在相对较长的时间间隔。用于在早期识别 BD 甚至在首次躁狂发作之前识别 BD 的策略可以帮助确定影响疾病发生和病程的风险和修饰因素,并改善结局。本文借鉴当前的研究结果,提出了双相障碍发展的危险因素的考虑因素,包括遗传/家族风险、表型和临床特征。总之,本文为双相障碍前驱期的研究以及在双相障碍出现之前和之后及时识别和治疗患者提供了框架和工具。